What is Vaxcyte, Inc.'s AOCI?

Vaxcyte, Inc. (PCVX) reported AOCI of -$6.83M in Q1 2026.

How has Vaxcyte, Inc.'s AOCI changed year-over-year?

Vaxcyte, Inc.'s AOCI decreased by 2022.4% year-over-year, from -$322K to -$6.83M.

What is the long-term trend for Vaxcyte, Inc.'s AOCI?

Over 4 years (2021 to 2025), Vaxcyte, Inc.'s AOCI has grown at a 60.2% compound annual growth rate (CAGR), from -$241K to $1.59M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Vaxcyte, Inc. PCVX AOCI

AOCI at other companies

PfizerPFE

-$7.2B+16.1%

Merck & Co.MRK

-$4.06B+18.2%

ModernaMRNA

$25M+150%

Krystal Biotech, Inc.KRYS

-$1.62M-516%

ImmunityBio, Inc.IBRX

$27.45M+37.6%

Vertex PharmaceuticalsVRTX

$24.8M-63.6%

Other financials

Income statement

See full

Operating income-$345.9M-91.3%

Net income-$320.6M-128%

EPS (diluted)-$2.30-121%

Balance sheet

See full

Cash & equivalents$262.3M-24.7%

Total debt$116.3M+33.5%

Total equity$3.0B-6.4%

Total assets$3.3B-0.9%

Cash flow

See full

Operating cash flow-$280.6M-68.8%

CapEx$2.1M-61.2%

Free cash flow-$282.7M-64.7%

Valuation

See full

Market cap$7.43B+72.0%

Enterprise value$7.28B+78.6%

Returns & leverage

See full

Return on equity-30.6%+37.9pp

Debt / equity0×0.0×

Current ratio7.5×-10.2×

Where this comes from

Reported directly by Vaxcyte, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vaxcyte, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vaxcyte, Inc.'s AOCI?: Vaxcyte, Inc. (PCVX) reported AOCI of -$6.83M in Q1 2026.
How has Vaxcyte, Inc.'s AOCI changed year-over-year?: Vaxcyte, Inc.'s AOCI decreased by 2022.4% year-over-year, from -$322K to -$6.83M.
What is the long-term trend for Vaxcyte, Inc.'s AOCI?: Over 4 years (2021 to 2025), Vaxcyte, Inc.'s AOCI has grown at a 60.2% compound annual growth rate (CAGR), from -$241K to $1.59M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.